Chiome Bioscience Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1,006	2,063	1,326	1,727	1,791	2,686
Cash & Short-Term Investments	1,006	2,063	1,326	1,727	1,791	2,686
Cash Growth	-18.97%	55.65%	-23.26%	-3.56%	-33.33%	27.56%
Accounts Receivable	47.37	51.06	83.19	115.22	25.46	56.78
Other Receivables	30.73	24.43	25.05	29.57	36.05	57.57
Receivables	78.1	75.49	108.24	144.79	61.51	114.35
Inventory	53.1	46.17	64.11	71.48	59.05	89.26
Prepaid Expenses	-	46.66	43.85	57.15	34.47	34.99
Other Current Assets	225.28	106.08	87.65	91.48	270.87	323.6
Total Current Assets	1,362	2,338	1,629	2,092	2,217	3,249
Property, Plant & Equipment	38.85	-	1.17	2.44	4.2	7.16
Long-Term Investments	-	-	-	-	-	150
Other Long-Term Assets	148.36	131.19	120.89	120.87	118.36	88.88
Total Assets	1,549	2,469	1,751	2,215	2,339	3,495
Accounts Payable	35.22	27.2	37.74	31.87	29.81	40.11
Accrued Expenses	9.54	29.56	32.32	32.91	44.46	36.69
Short-Term Debt	79.4	281.5	291	184	183	180
Current Income Taxes Payable	7.15	2.53	23.95	23.94	16.75	3.24
Other Current Liabilities	112.55	152.65	154.03	97.74	118.53	82.68
Total Current Liabilities	243.86	493.43	539.04	370.46	392.54	342.71
Other Long-Term Liabilities	55.45	55.12	54.69	54.27	53.85	41.87
Total Liabilities	299.3	548.55	593.73	424.72	446.39	384.59
Common Stock	1,066	995.53	2,388	2,097	1,516	1,388
Retained Earnings	184.8	915.02	-1,248	-319.53	342.02	1,694
Treasury Stock	-0.29	-0.29	-0.29	-0.29	-0.29	-0.29
Comprehensive Income & Other	0.06	10.05	17.74	13.55	35.4	28.92
Total Common Equity	1,250	1,920	1,158	1,791	1,893	3,110
Shareholders' Equity	1,250	1,920	1,158	1,791	1,893	3,110
Total Liabilities & Equity	1,549	2,469	1,751	2,215	2,339	3,495
Total Debt	79.4	281.5	291	184	183	180
Net Cash (Debt)	926.35	1,782	1,035	1,543	1,608	2,506
Net Cash Growth	-1.27%	72.23%	-32.96%	-4.03%	-35.84%	19.01%
Net Cash Per Share	13.85	30.61	20.88	35.09	39.92	69.85
Filing Date Shares Outstanding	68.04	66.96	52.63	48.42	40.78	39.51
Total Common Shares Outstanding	68.04	66.96	52.63	48.42	40.78	39.51
Working Capital	1,118	1,844	1,090	1,722	1,824	2,906
Book Value Per Share	18.37	28.68	22.00	36.98	46.42	78.72
Tangible Book Value	1,250	1,920	1,158	1,791	1,893	3,110
Tangible Book Value Per Share	18.37	28.68	22.00	36.98	46.42	78.72
Machinery	332.49	312.86	318.96	351.63	387.39	391.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.